Previous 10 | Next 10 |
home / stock / love:cc / love:cc news
Montreal, Quebec--(Newsfile Corp. - May 23, 2023) - Cannara Biotech Inc (TSXV: LOVE) announced today that it will be presenting at the 13th Annual LD Micro Invitational at the Luxe Sunset Boulevard Hotel, California on June 6th-8th, 2023. The event is expected to feature 150+ companies, present...
Cannara Biotech Inc. To Participate At Canaccord Genuity's 7th Annual Global Cannabis Conference PR Newswire MONTREAL , May 11, 2023 /PRNewswire/ - Cannara Biotech Inc. (" Cannara " or the " Company ") (TSXV: LOVE) (OTCQB: LOVFF) (FRA: 8CB), a vertica...
CANARA BIOTECH INC. SECURES AN ADDITIONAL $10 MILLION IN NON-DILUTIVE CAPITAL WITH ITS LEAD CREDIT PROVIDER, BMO COMMERCIAL BANKING Canada NewsWire MONTREAL , May 4, 2023 /CNW/ - Cannara Biotech Inc. (" Cannara " or the " Company ") (TSXV: LOVE) (OTCQ...
Cannara Biotech Inc. to Host Investor Webcast on May 4th, 2023 Canada NewsWire MONTREAL , April 25, 2023 /CNW/ - Cannara Biotech Inc. (" Cannara " or the " Company ") (TSXV: LOVE) (OTCQB: LOVFF) (FRA: 8CB), a vertically integrated producer of premium-...
Cannara Biotech Inc. reports Q2 2023 Financial Results with quarterly net revenues of $13 million, a 76% increase compared to Q2 2022 Canada NewsWire Six-month net revenues of $23.4 million , a 67% increase compared to first half 2022 Delivered its eighth consecutive qua...
Cannara Biotech Inc. Enters into an Automatic Share Purchase Plan Canada NewsWire MONTREAL , Feb. 28, 2023 /CNW/ - Cannara Biotech Inc. (" Cannara " or the " Company ") (TSXV: LOVE) (OTCQB: LOVFF) (FRA: 8CB), a vertically integrated producer of premiu...
CANNARA BIOTECH INC. ANNOUNCES RESULTS OF ANNUAL SHAREHOLDER MEETING AND CONVERSION INTO EQUITY OF A $5M CONVERTIBLE DEBENTURE AT $0.18 CENT PER COMMON SHARE Canada NewsWire MONTREAL , Feb. 10, 2023 /CNW/ - Cannara Biotech Inc. (" Cannara " or the " Com...
Cannara Biotech Inc. Reports Q1 2023 Financial Results Canada NewsWire Company recorded $10.3 million in quarterly revenue; a 57% increase compared to Q1 2022 Delivered its seventh consecutive quarter of positive Adjusted EBITDA of $1.7M and reported positive net inc...
Cannara Announces Proposed Share Consolidation Canada NewsWire MONTREAL , Jan. 12, 2023 /CNW/ - Cannara Biotech Inc. (" Cannara " or the " Company ") (TSXV: LOVE) (OTCQB: LOVFF) (FRA: 8CB), a vertically integrated producer of premium-grade cannabis an...
Cannara Announces Normal Course Issuer Bid for Common Shares of the Corporation Canada NewsWire MONTREAL , Nov. 30, 2022 /CNW/ - Cannara Biotech Inc. (" Cannara " or the " Company ") (TSXV: LOVE) (OTCQB: LOVFF) (FRA: 8CB), a vertically integrated prod...
News, Short Squeeze, Breakout and More Instantly...
Cannara Biotech Inc. Company Name:
LOVE:CC Stock Symbol:
TSXVC Market:
Cannara Biotech Inc. Website:
A look at the top 10 most actives in Canada Fission Uranium Corp. (FCU) rose 2.3% to $1.36 on volume of 2,971,913 shares Toronto-Dominion Bank (The) (TD) rose 0.2% to $76.18 on volume of 1,841,208 shares B2Gold Corp. (BTO) rose 1.9% to $3.945 on volume of 1,428,715 shares Puma Explorati...
Cannara Biotech Reports Q2 2024 Financial Results Canada NewsWire Net revenue, increased to $19.7 million in Q2 2024 from $13.0 million in Q2 2023, a 51.0% increase. Gross profit, before fair value adjustments, increased to $7.1 million in Q2 2024 from $4...
--News Direct-- Cannara Biotech Inc CFO Nicholas Sosiak joined Steve Darling from Proactive to provided valuable insights into the company's success in the cannabis industry. Cannara, based in Montreal, Canada, is a licensed producer with two facilities totaling 1.6 million square fee...